Canton Strategic Holdings CNTN
NASDAQ CNTN
$2.28 +0.03 (+1.33%)
As of: Sep 4, 2026 · 3:59 PM EDT

Canton Strategic Holdings (CNTN) Share-based Compensation (2020 - 2026)

Canton Strategic Holdings' (CNTN) quarterly Share-based Compensation came in at $32.3 million in Q1 2026, up 14618.45% YoY from N/an in Q1 2025, and up 1951.78% on a QoQ basis from $1.6 million in Q4 2025.

Analysis

Canton Strategic Holdings (CNTN) Share-based Compensation (2020 - 2026) Analysis & Trends

Canton Strategic Holdings (CNTN) has 6 years of Share-based Compensation data on file, last reported at $32.3 million in Q1 2026.

  • Quarterly Share-based Compensation rose 14618.45% year-over-year to $32.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $34.6 million (up 4358.39% YoY) and the FY2025 annual result came in at $2.9 million, up 305.15% from the prior year.
  • Share-based Compensation rose to $32.3 million in Q1 2026, from $1.6 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $32.3 million in Q1 2026 to a low of $19381.0 in Q1 2022.
  • A 5-year average of $2.2 million and a median of $202002.0 in 2022 frame the typical range for Share-based Compensation.
  • Annual changes were most pronounced in 2022 — Share-based Compensation tumbled 97.12% — and 2026, when it surged 14618.45%.
  • Tracing CNTN's Share-based Compensation over 5 years: stood at $202002.0 in 2022, then tumbled by 50.5% to $100000.0 in 2023, then jumped by 111.1% to $211104.0 in 2024, then jumped by 644.79% to $1.6 million in 2025, then surged by 1951.78% to $32.3 million in 2026.
  • The last three Share-based Compensation figures came in at $32.3 million (Q1 2026), $1.6 million (Q4 2025), and $200000.0 (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 108.10 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 243.00 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 120.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 277.20 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 137.41 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 86.63 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 41.25 Mn
10 Canton Strategic Holdings 493.37 Mn 493.37 Mn - 656,163.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 656,163.00
Mar 31, 2026 32.26 Mn
Dec 31, 2025 1.57 Mn
Sep 30, 2025 1.21 Mn
Jun 30, 2025 567,636.00
Mar 31, 2025 242,788.00
Dec 31, 2024 211,104.00
Sep 30, 2024 191,943.00
Jun 30, 2024 153,647.00
Mar 31, 2024 153,619.00
Dec 31, 2023 170,443.00
Sep 30, 2023 157,960.00
Jun 30, 2023 158,027.00
Mar 31, 2023 345,432.00
Dec 31, 2022 202,002.00
Sep 30, 2022 240,762.00
Jun 30, 2022 338,551.00
Mar 31, 2022 1.82 Mn
Dec 31, 2021 6,742.00
Sep 30, 2021 4,435.00